Major depressive disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Aged 18 to 59 years, and right-handed; 2.Patients who have received systematic antidepressant treatment (including antidepressant medications, sedative-hypnotics, electroconvulsive therapy, or transcranial magnetic stimulation) within the 4 weeks prior to enrollment; 3.Having a total score on the 17-item Hamilton Depression Rating Scale (HAMD-17) greater than 7 and less than or equal to 24; 4.Voluntary participation in the study, with written informed consent provided by the patient themselves or their legally authorized guardian.
Exclusion criteria
Exclusion criteria: 1.Diagnosis of other major psychiatric disorders or presence of psychotic symptoms. 2.History of other severe somatic diseases (e.g., cardiovascular/cerebrovascular diseases, autoimmune diseases), or current/past neurological or organic brain diseases. 3.Current or past history of alcohol dependence or abuse of other psychoactive substances. 4.Women who are lactating, pregnant, or menstruating. 5.Patients who have participated in other clinical drug trials within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Montgomery-Åsberg Depression Rating Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hamilton Depression Rating Scale;Positive and Negative Affect Schedule;Maudsley Three-Item Visual Analogue Scale; | — |
Countries
China
Contacts
Tsinghua University Yuquan Hospital (Tsinghua University Hospital of Integrated Traditional Chinese and Western Medicine)